北京热景生物技术股份有限公司 简式权益变动报告书

Core Viewpoint - The report details the shareholding changes of Beijing Hotgen Biotech Co., Ltd. (referred to as "the company") due to a reduction in shares held by the information discloser, Lin Changqing, based on personal financial needs [4][5]. Group 1: Shareholding Changes - As of the report date, Lin Changqing and his action group held a total of 24,093,844 shares, accounting for 25.99% of the company's total equity, with Lin holding 21,682,487 shares (23.39%) and the action group holding 2,411,357 shares (2.60%) [6]. - Following the share reduction, the total shares held by Lin and his action group decreased to 23,176,985 shares, representing 25% of the total equity, with Lin now holding 20,765,628 shares (22.40%) and the action group maintaining 2,411,357 shares (2.60%) [6][8]. Group 2: Reduction Details - The share reduction occurred between September 24, 2025, and October 28, 2025, during which Lin Changqing sold 916,859 shares, resulting in a decrease in his shareholding percentage from 23.39% to 22.40% [8]. - The action group's total shareholding percentage also decreased from 25.99% to 25% as a result of this transaction [8]. Group 3: Future Plans - Lin Changqing has a plan to reduce his holdings by up to 1,000,000 shares within three months following the announcement of the reduction plan on August 15, 2025, which represents approximately 1.0787% of the company's total equity [5]. - As of the report date, there are no additional plans or agreements to increase or decrease shareholdings in the next 12 months [5].